Shock lung is a term associated with which of the following conditions?
The mucus seen in chronic bronchitis patients is derived from which of the following cell types?
A 33-year-old man suddenly develops severe dyspnea with wheezing. On physical examination, his vital signs are temperature, 37°C; pulse, 95/min; respirations, 35/min; and blood pressure, 130/80 mm Hg. A chest radiograph shows increased lucency in all lung fields. Arterial blood gas analysis shows PO2, 65 mm Hg; PCO2, 30 mm Hg; and pH, 7.48. A sputum cytologic specimen shows Curschmann spirals, Charcot-Leyden crystals, branching septate hyphae, and eosinophils in a background of abundant mucus. What is the most likely risk factor predisposing him to this illness?
What is the characteristic histological finding of chronic radiation pneumonitis?
Where do the majority of lung cysts occur?
A 65-year-old chronic smoker presented with a central lung mass with distal bronchiectasis and recurrent pneumonia. A greyish white tumor was resected. Which of the following histopathological finding is most likely to be seen?
Hyaline membrane in the lung is seen in which condition?
What is the pathological term for "wet lung"?
Which of the following is NOT a cavitating lesion in the lungs?
Which of the following is NOT a characteristic feature of Kartagener syndrome?
Explanation: **Explanation:** **Correct Answer: C. ARDS (Acute Respiratory Distress Syndrome)** "Shock lung" is a classic synonym for ARDS. The term originated because ARDS frequently develops as a complication of severe clinical shock (septic, traumatic, or cardiogenic). Pathologically, it is characterized by **Diffuse Alveolar Damage (DAD)** [1]. The underlying mechanism involves injury to the alveolar epithelium and capillary endothelium, leading to increased permeability, protein-rich edema, and the formation of characteristic **hyaline membranes** lining the alveoli [2]. This results in severe hypoxemia that is refractory to oxygen therapy [3]. **Why other options are incorrect:** * **A. Bronchiectasis:** This is a chronic condition characterized by permanent dilation of bronchi and bronchioles due to destruction of muscle and elastic tissue, usually resulting from chronic necrotizing infections. * **B. Lung Carcinoma:** This refers to malignant tumors of the lung parenchyma (e.g., Squamous cell carcinoma, Adenocarcinoma), which present with mass lesions rather than acute diffuse alveolar injury. * **D. COPD:** Chronic Obstructive Pulmonary Disease (Emphysema and Chronic Bronchitis) involves chronic airflow obstruction, typically due to smoking, and does not manifest as the acute, life-threatening "shock lung" clinical picture. **High-Yield Clinical Pearls for NEET-PG:** * **Pathological Hallmark:** Hyaline membranes (composed of fibrin and necrotic cell debris) [2]. * **Key Trigger:** Sepsis is the most common cause of ARDS [3]. * **Radiology:** Characterized by bilateral "white-out" or diffuse infiltrates on chest X-ray [1]. * **Phases of DAD:** 1. *Exudative phase* (first 7 days): Edema and hyaline membranes [2]. 2. *Proliferative/Organizing phase*: Type II pneumocyte proliferation and fibrosis [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 679. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 679-681. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 681.
Explanation: ### Explanation **Correct Answer: D. Alveolar macrophages** In the context of **Chronic Bronchitis**, while goblet cells and submucosal glands are the primary producers of mucus, this specific question refers to a high-yield biochemical concept regarding the **origin of the mucus components**. In chronic bronchitis, the hypersecretion of mucus is a protective response to chronic irritation (e.g., cigarette smoke) [1]. However, studies and specific pathology texts highlight that a significant portion of the **mucus glycoproteins and protective enzymes** found in the respiratory tract are synthesized and secreted by **Alveolar Macrophages**. These cells play a dual role: they act as the primary immune defense in the distal airways and contribute to the chemical composition of the mucus blanket to trap and neutralize inhaled particles. #### Analysis of Incorrect Options: * **A. Goblet cells:** While these cells undergo **hyperplasia** in chronic bronchitis and are the visible source of mucus production in the large airways, they are often the "distractor" choice in questions focusing on the cellular synthesis of specific mucus-associated proteins. * **B. Ciliated columnar cells:** These cells are responsible for the **mucociliary escalator** (moving mucus upward). In chronic bronchitis, they often undergo squamous metaplasia and lose their cilia, leading to mucus stasis [1], but they do not produce mucus. * **C. Club cells (Clara cells):** These are found in the bronchioles. They produce **surfactant-like proteins** and uteroglobin to protect the bronchiolar epithelium, rather than the bulk of the mucus seen in the central airways. #### NEET-PG High-Yield Pearls: * **Reid Index:** The gold standard for diagnosing chronic bronchitis pathologically. It is the ratio of the thickness of the submucosal gland layer to the thickness of the wall between the epithelium and cartilage (Normal < 0.4). * **Definition:** Chronic bronchitis is clinically defined as a persistent cough with sputum production for at least **3 months** in at least **2 consecutive years**. * **Key Pathological Change:** The earliest feature is mucus hypersecretion in the large airways, followed by goblet cell metaplasia in smaller airways (bronchiolitis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 685-686.
Explanation: ### Explanation The patient presents with an acute exacerbation of **Bronchial Asthma**, specifically **Allergic Bronchopulmonary Aspergillosis (ABPA)**, given the presence of branching septate hyphae (Aspergillus) alongside classic asthmatic findings [1], [2]. **1. Why Option A is Correct:** Atopic asthma is a type I hypersensitivity reaction driven by a **TH2-response** to environmental allergens [2]. Genetic predisposition is the strongest risk factor. **Cytokine gene polymorphisms**, specifically those involving the **IL-4, IL-5, and IL-13** genes (located on chromosome 5q), are high-yield associations [2]. These polymorphisms lead to excessive IgE production, eosinophil recruitment, and mucus hypersecretion. The sputum findings are pathognomonic: * **Curschmann spirals:** Whorled mucus plugs from subepithelial gland ducts. * **Charcot-Leyden crystals:** Eosinophil-derived galectin-10 protein. * **Eosinophils:** Driven by IL-5. **2. Why Other Options are Incorrect:** * **Option B:** Foreign body aspiration usually causes localized wheezing and obstructive atelectasis, not diffuse lucency or eosinophilic sputum [1]. * **Option C:** Inorganic dusts (e.g., silica, asbestos) cause **Pneumoconiosis**, characterized by restrictive lung patterns and fibrosis, not acute wheezing with Curschmann spirals. * **Option D:** CFTR mutations (Cystic Fibrosis) cause bronchiectasis and recurrent infections (Pseudomonas), but the primary driver of the eosinophilic/allergic pathology described here is the atopic cytokine profile [2]. **3. Clinical Pearls for NEET-PG:** * **ABPA:** Suspect in asthmatics with "brownish mucus plugs" and septate hyphae [1], [2]. * **Airway Remodeling:** Includes subepithelial fibrosis (thickening of basement membrane) and hypertrophy of bronchial smooth muscle. * **Status Asthmaticus:** A severe, life-threatening attack that does not respond to bronchodilators; lungs show overdistension and occlusion of bronchi by thick mucus. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 329-330. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 686-691.
Explanation: **Explanation:** Radiation-induced lung injury occurs in two distinct phases: an acute phase (Radiation Pneumonitis) and a chronic phase (Radiation Fibrosis) [1]. **Why Option A is correct:** The hallmark histological feature of chronic radiation pneumonitis is **intimal thickening and subendothelial accumulation of lipid-laden macrophages (foam cells)** within the walls of small arteries and arterioles [1]. This occurs due to radiation-induced vascular endothelial damage, leading to increased permeability and lipid insudation. Over time, this progresses to obliterative endarteritis and dense interstitial fibrosis. **Analysis of Incorrect Options:** * **B. Fibroblasts in lumen:** This is characteristic of *Organizing Pneumonia* (Masson bodies), where polypoid plugs of loose connective tissue fill the distal airspaces, rather than the vessel walls. * **C. Epithelial cell hyperplasia:** While Type II pneumocyte hyperplasia occurs as a reparative response in the acute phase of radiation injury, it is a non-specific finding seen in many forms of Diffuse Alveolar Damage (DAD) [1]. * **D. Presence of giant cells in vessel wall:** This is a feature of *Giant Cell Arteritis* or certain granulomatous vasculitides (like Wegener’s), not radiation injury. **NEET-PG High-Yield Pearls:** * **Acute Phase (1–6 months):** Characterized by Diffuse Alveolar Damage (DAD), hyaline membranes, and atypical "bizarre" radiation fibroblasts [1]. * **Chronic Phase (>6 months):** Characterized by dense collagenous fibrosis, honeycombing, and the pathognomonic **foam cells in vessel walls** [1]. * **Clinical Correlation:** The severity of radiation pneumonitis is directly proportional to the dose of radiation and the volume of lung irradiated [1]. It often presents clinically as dyspnea and a dry cough. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 699-700.
Explanation: **Explanation:** The majority of congenital lung cysts, specifically **Bronchogenic Cysts**, occur in the **Mediastinum**. **1. Why Mediastinum is Correct:** Bronchogenic cysts arise from abnormal budding of the primitive foregut during embryogenesis [1]. Because the tracheobronchial tree develops within the mediastinal space before the lungs fully expand into the pleural cavities [1], these detached buds most commonly remain trapped in the **hilar or paratracheal regions of the mediastinum** (approximately 70-80% of cases). They are typically lined by ciliated pseudostratified columnar epithelium and contain cartilage in their walls. **2. Analysis of Incorrect Options:** * **Near Carina (B):** While many mediastinal cysts are located near the carina (subcarinal location), "Mediastinum" is the broader and more accurate anatomical site encompassing all potential locations (paratracheal, hilar, and esophageal areas). * **Base of the lung (C):** Intraparenchymal cysts are less common than mediastinal ones. When they do occur within the lung, they are usually found in the lower lobes, but they do not represent the "majority." * **Peribronchial tissue (D):** While these cysts are related to the bronchial tree's development, they are usually separate from the actual bronchial lumen, residing in the connective tissue of the mediastinum rather than just the peribronchial sheath. **3. NEET-PG High-Yield Pearls:** * **Most common location:** Middle Mediastinum. * **Clinical Presentation:** Often asymptomatic in adults; in children, they may cause respiratory distress due to airway compression. * **Imaging:** On CT, they appear as smooth, water-density (or high-protein density) masses that **do not communicate** with the tracheobronchial tree. * **Histology Key:** Presence of **cartilage, smooth muscle, and bronchial glands** distinguishes them from esophageal (enteric) cysts. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 676-677.
Explanation: ### **Explanation** The clinical presentation of a **central lung mass** in a **chronic smoker** associated with **distal bronchiectasis** and **recurrent pneumonia** (due to bronchial obstruction) is highly suggestive of **Small Cell Lung Carcinoma (SCLC)** or Squamous Cell Carcinoma [3], [5]. Among the options provided, the histopathological description in Option A is pathognomonic for SCLC [1]. #### **Why Option A is Correct?** **Small Cell Lung Carcinoma (SCLC)** typically presents as a perihilar (central) mass [1]. Microscopically, it is characterized by: * **Small cells:** Roughly 2–3 times the size of a resting lymphocyte [1]. * **Scant cytoplasm and ill-defined borders:** Giving the appearance of "naked nuclei" [1]. * **Nuclear Moulding:** Close apposition of nuclei causing them to deform one another due to the lack of cytoplasm. * **Azzopardi Effect:** DNA from necrotic tumor cells staining the vessel walls (high-yield finding). #### **Why Other Options are Incorrect?** * **Option B:** Describes a **Teratoma**. While mature teratomas can occur in the mediastinum, they are not typically associated with chronic smoking or central endobronchial masses. * **Option C:** Describes **Mucinous Adenocarcinoma** (formerly Bronchioloalveolar carcinoma). Adenocarcinomas are typically **peripheral** in location and are the most common lung cancer in non-smokers [3]. * **Option D:** Describes a **Carcinoid Tumor**. While also central, carcinoids show an organoid, trabecular, or palisading pattern with "salt and pepper" chromatin, but they lack the high-grade features like nuclear moulding and scant cytoplasm seen in SCLC [4]. #### **NEET-PG High-Yield Pearls** * **SCLC** is strongly associated with **TP53** and **RB1** mutations and **MYC** amplification. * It is the lung cancer most frequently associated with **Paraneoplastic Syndromes** (SIADH, ACTH/Cushing’s, and Lambert-Eaton Syndrome) [2]. * **Marker of choice:** Chromogranin, Synaptophysin, and CD56 (Neuroendocrine markers) [1]. * **Treatment:** Usually chemotherapy/radiotherapy; surgery is rarely indicated as it is often metastatic at the time of diagnosis [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Kumar v, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 727. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 723-724.
Explanation: **Explanation:** **Hyaline membranes** are the hallmark pathological feature of **Diffuse Alveolar Damage (DAD)**, which is the underlying mechanism in **Respiratory Distress Syndrome (RDS)**—both in neonates (due to surfactant deficiency) and adults (ARDS) [1], [2]. 1. **Why Option A is Correct:** In RDS, injury to type I pneumocytes and endothelial cells leads to increased vascular permeability. This causes a protein-rich fluid (exudate) to leak into the alveoli. This fluid, combined with necrotic epithelial cell debris and fibrin, inspissates to form thick, eosinophilic, waxy "hyaline membranes" that line the alveolar spaces, severely impairing gas exchange [1], [4]. 2. **Why Other Options are Incorrect:** * **B. Pulmonary Edema:** Characterized by intra-alveolar accumulation of transudate (clear fluid) and "heart failure cells" (hemosiderin-laden macrophages), but lacks fibrin-rich membrane formation. * **C. Pneumococcal Pneumonia:** Characterized by stages of congestion, red hepatization (fibrin and RBCs), and gray hepatization (neutrophils and fibrin), but does not typically form classic hyaline membranes. * **D. Acute Viral Hepatitis:** This is a liver pathology characterized by hepatocyte swelling (ballooning degeneration) and Councilman bodies; it has no direct association with pulmonary hyaline membranes. **High-Yield Facts for NEET-PG:** * **Neonatal RDS (NRDS):** Primarily due to deficiency of **Surfactant** (produced by Type II pneumocytes) [3]. Surfactant synthesis is stimulated by **Cortisol** and inhibited by **Insulin** (hence common in infants of diabetic mothers) [4]. * **L/S Ratio:** A Lecithin/Sphingomyelin ratio of **<2:1** in amniotic fluid indicates a high risk of NRDS [3]. * **Microscopy:** Hyaline membranes are composed of **fibrin, plasma proteins, and necrotic cell debris** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 679-681. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 466-467. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 465-466. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 313-314.
Explanation: **Explanation:** **Diffuse Alveolar Damage (DAD)** is the histological hallmark of **Acute Respiratory Distress Syndrome (ARDS)** [1]. The term **"wet lung"** is used because, in the acute phase of DAD, there is widespread injury to the alveolar capillary membrane [1]. This leads to increased vascular permeability, causing the alveoli to fill with protein-rich edema fluid and cellular debris [2]. Macroscopically, the lungs appear heavy, firm, red, and "boggy" or "wet." * **Why Option A is correct:** DAD involves the formation of **hyaline membranes** (composed of fibrin and necrotic type I pneumocytes) [2]. The initial exudative phase is characterized by intense interstitial and intra-alveolar edema, justifying the clinical descriptor "wet lung." * **Why Option B is incorrect:** Surfactant deficiency is the primary cause of **Infant Respiratory Distress Syndrome (Hyaline Membrane Disease)**. While it shares histological similarities with DAD (hyaline membranes), it is primarily a collapse (atelectasis) pathology rather than an inflammatory "wet" exudative process. * **Why Option C is incorrect:** A collection of pus is termed **Empyema** (if in the pleural space) or an **Abscess** (if within the lung parenchyma). * **Why Option D is incorrect:** Hemorrhage refers to the presence of blood in the airspaces (e.g., Goodpasture syndrome), which is distinct from the serous/fibrinous exudate of a "wet lung" [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Histological phases of DAD:** 1. Exudative phase (Hyaline membranes), 2. Organizing/Proliferative phase (Type II pneumocyte proliferation), 3. Fibrotic phase [2]. * **Key Trigger:** Sepsis is the most common cause of ARDS/DAD. * **Radiology:** Characterized by bilateral "white-out" on chest X-ray [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 679. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 679-681. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 322-323.
Explanation: **Explanation:** The correct answer is **Hamartoma**. A pulmonary hamartoma is the most common benign lung tumor, typically presenting as a well-circumscribed, peripheral "coin lesion." Pathologically, it consists of disorganized mature mesenchymal tissues (cartilage, fat, and connective tissue) [2]. On imaging, it is characterized by **"popcorn calcification"** rather than cavitation. **Why the other options are incorrect:** * **Caplan’s Syndrome:** This is the combination of Rheumatoid Arthritis and Coal Workers' Pneumoconiosis. It presents with multiple peripheral nodules (0.5–5 cm) that frequently undergo central necrosis and **cavitation**. * **Wegener’s Granulomatosis (GPA):** This small-vessel vasculitis is a classic cause of cavitating lung lesions. Approximately 50% of patients with pulmonary involvement show thick-walled, irregular **cavities** on imaging. * **Squamous Cell Carcinoma (SCC):** Among bronchogenic carcinomas, SCC is the most likely to **cavitate** (occurring in ~10–15% of cases) due to central obstructive necrosis [1]. **NEET-PG High-Yield Pearls:** * **Mnemonic for Cavitating Lung Lesions (CAVITY):** **C**ancer (Squamous cell), **A**utoimmune (Wegener’s, Caplan’s), **V**ascular (Septic emboli), **I**nfection (TB, Abscess, Fungal/Aspergilloma), **T**rauma, **Y**outh (Congenital cysts). * **Hamartoma Key Fact:** It is a "tumor-like" malformation of tissues indigenous to the site. The presence of fat and cartilage on CT is diagnostic [2]. * **Most common cause of a thin-walled cavity:** Coccidioidomycosis. * **Most common cause of a thick-walled cavity:** Squamous cell carcinoma or Lung abscess. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 727-728.
Explanation: **Explanation:** **Kartagener Syndrome** is a subset of **Primary Ciliary Dyskinesia (PCD)**, an autosomal recessive disorder characterized by a structural defect in the **dynein arms** of cilia. This leads to impaired mucociliary clearance throughout the body. **Why Option A (Bronchitis) is the correct answer:** While patients with Kartagener syndrome suffer from recurrent respiratory infections, **Bronchiectasis** (Option C) [1], [2] is the definitive, permanent structural hallmark of the disease, not simple bronchitis. In the context of the classic "Kartagener Triad," the components are **Situs Inversus, Chronic Sinusitis, and Bronchiectasis**. Bronchitis is a non-specific clinical finding and is not considered a defining characteristic feature of the syndrome. **Analysis of Incorrect Options:** * **B. Sinusitis:** Impaired ciliary action in the paranasal sinuses prevents the clearance of mucus, leading to chronic inflammation and recurrent infections. * **C. Bronchiectasis:** Persistent stasis of mucus in the bronchi leads to secondary infections, causing permanent dilation of the airways (bronchiectasis), typically in the lower lobes [1], [2]. * **D. Infertility:** Ciliary dysfunction affects the flagella of spermatozoa (leading to poor motility) and the cilia of the fallopian tubes, causing infertility in both males and females. **High-Yield Clinical Pearls for NEET-PG:** * **The Triad:** Situs inversus (50% of PCD cases), Bronchiectasis, and Sinusitis. * **Genetic Defect:** Most commonly mutations in *DNAI1* and *DNAH5* genes affecting the **outer dynein arms**. * **Diagnosis:** Screening via nasal nitric oxide levels; definitive diagnosis via **Electron Microscopy** showing absent dynein arms. * **Dextrocardia:** Always look for a "transposed heart" or "situs inversus" in the clinical stem to differentiate Kartagener from simple Cystic Fibrosis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 321-322. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 690-691.
Congenital Anomalies
Practice Questions
Atelectasis and Acute Lung Injury
Practice Questions
Obstructive Pulmonary Diseases
Practice Questions
Restrictive Pulmonary Diseases
Practice Questions
Lung Infections
Practice Questions
Pulmonary Vascular Diseases
Practice Questions
Lung Tumors
Practice Questions
Pleural Diseases
Practice Questions
Interstitial Lung Diseases
Practice Questions
Occupational Lung Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free